Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.6300
-0.0251 (-3.83%)
Mar 31, 2025, 2:31 PM EDT - Market open
Context Therapeutics Employees
Context Therapeutics had 5 employees as of December 31, 2023. The number of employees decreased by 4 or -44.44% compared to the previous year.
Employees
5
Change (1Y)
-4
Growth (1Y)
-44.44%
Revenue / Employee
n/a
Profits / Employee
-$5,345,021
Market Cap
56.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | 8 | 800.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CNTX News
- 4 days ago - Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 10 days ago - Context Therapeutics Reports Full Year 2024 Operating and Financial Results - GlobeNewsWire
- 4 weeks ago - Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Context Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76 - GlobeNewsWire
- 2 months ago - Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors - GlobeNewsWire
- 5 months ago - Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 5 months ago - Context Therapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewsWire